Study guide

Pharmacokinetics: Drug Absorption, Distribution, Metabolism, and Excretion (ADME)

Veterinary Technician National Examination VTNE

Track your progress as you read

Finished sections get a check mark.

1 Pharmacology Foundations and Drug Classifications

Drug Classifications: Controlled Substance Schedules, Mechanism-Based Categories, and Therapeutic Classes Pharmacokinetics: Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Drug Side Effects, Adverse Reactions, Contraindications, and Drug-Drug Interactions

2 Dosage Calculations and Fluid Therapy

Dosage Calculations: mg/kg to Volume, Body Surface Area, and Metric System Conversions Fluid Therapy Rate Calculations and Continuous Rate Infusions (CRIs)

3 Medication Preparation, Dispensing, and Controlled Substances

Medication Preparation, Compounding, and Dispensing per Veterinarian Orders Controlled Drug Inventory, Logbooks, Legal Compliance, Storage, Handling, and Safe Disposal

4 Surgical Preparation and Sterile Technique

Surgical Anatomy and Pathophysiology for Perioperative Planning Surgical Environment, Equipment, and Instrument Preparation Patient Preparation: Clipping, Surgical Scrub, Draping, and Positioning Sterile Surgical Technician Role: Gowning, Gloving, and Sterile Field Maintenance

5 Instrument Processing and Aseptic Maintenance

Circulating (Non-Sterile) Technician Role, Instrument Accountability, and Count Reconciliation Instrument Cleaning Methods: Manual, Soak, and Ultrasonic Sterilization Methods, Aseptic Technique, and Surgical Suite Maintenance

6 Veterinary Dentistry

Dental Anatomy, Pathophysiology, and the Triadan Tooth-Numbering System Dental Equipment, Instruments, and Maintenance Comprehensive Oral Health Assessment and Treatment (COHAT): Scaling, Polishing, Charting, and Periodontal Assessment Dental Radiography: Positioning, Exposure, Safety, and Interpretation

7 Specimen Handling and Hematology

Specimen Collection, Preparation, Handling, Storage, and Shipping for In-House and Reference Labs Hematology: CBC Interpretation, Blood Smear Preparation, and Manual Cell Counting Cytology and Serology Procedures and Interpretation

8 Clinical Chemistry, Urinalysis, Parasitology, and Lab Quality

Clinical Chemistry, Urinalysis, Parasitology, and Microbiology Procedures Laboratory Equipment Maintenance, Calibration, Controls, and Quality Assurance

9 Patient Evaluation, Assessment, and Environment

Patient Anatomy, Physiology, and Pathophysiology for Nursing Care Initial and Ongoing Patient Evaluation: Physical Exam, Mentation, TPR, and Documentation Clinical Diagnostic Procedures: Blood Pressure Measurement, Electrocardiography, and Tonometry Safe, Sanitary, and Comfortable Environment: Housing, Hygiene, and Infection Control

10 Nursing Procedures and Treatments

Catheterization Techniques: IV, Urinary, and Feeding Tube Placement and Maintenance Wound Management and Bandaging Techniques Medication Administration: Routes (Topical, IV, SQ, IM, Oral) and Techniques

11 Specimens, Behavior, Restraint, and Equipment

Specimen Collection for In-House and Outside Laboratory Evaluation Animal Behavior Recognition and Appropriate Response Safe Animal Handling and Restraint With and Without Equipment

12 Diagnostic Imaging and Radiation Safety

Imaging Anatomy and Pathophysiology for Radiographic Interpretation Radiographic Production, Patient Positioning, and Documentation for Quality Images Imaging Equipment Maintenance, ALARA Principles, and Radiation Safety Protocols

13 Anesthesia Foundations and Planning

13.1 Anesthesia Anatomy, Physiology, and Pathophysiology 13.2 Anesthetic Plan Development and Pre-anesthetic Assessment and Care 13.3 Anesthetic Medications: Pharmacology, Reactions, Contraindications, and Interactions

14 Anesthetic Equipment and Airway Management

Anesthetic Machine Preparation, Leak Testing, and Equipment Maintenance for Reliable Operation Endotracheal Intubation: Technique, Airway Management, and Troubleshooting

15 Anesthesia Monitoring and Recovery

Anesthesia Monitoring: Pre-Anesthetic, Peri-Operative, and Post-Operative Stages (EtCO2, SpO2, HR, BP, Temperature) Anesthesia Troubleshooting, Recovery Assessment, and Post-Anesthetic Care

16 Emergency Medicine and Critical Care

Emergency Anatomy, Pathophysiology, and Triage Prioritization Emergency Nursing Procedures: RECOVER CPR, Acute Blood Loss Control, and Fracture Stabilization Critical Care Nursing: Blood Component Therapy, Fluid Resuscitation, and Ongoing Oxygen Therapy Ongoing Patient Evaluation in Emergency and Critical Conditions

17 Pain Management and Analgesia

Pain Anatomy, Physiology, and Pathophysiology Foundations Pain Recognition and Assessment: Scoring Scales and Species-Specific Behavioral Indicators Multimodal Pain Management Plans: Analgesic Selection, Contraindications, and Implementation Analgesic Administration Techniques and Reassessment Cadence

18 Communication and Veterinary Professional Support Services

Client education: animal care, risks, side effects, preventative care, and zoonosis Professional communication, ethics, veterinary team interactions, and record keeping Patient information collection, signs of animal abuse, and euthanasia assistance (consent, aftercare, grief management)

Pharmacokinetics: Drug Absorption, Distribution, Metabolism, and Excretion (ADME)

Key Takeaways Explain This Topic AI

Cats have minimal hepatic glucuronidation (UGT1A6/UGT2B7) — acetaminophen is lethal even at single doses due to NAPQI accumulation; N-acetylcysteine is the antidote.

IV administration bypasses first-pass hepatic metabolism and gives 100% bioavailability; PO is the route most affected by first-pass metabolism.

Renal excretion (glomerular filtration, tubular secretion, reabsorption) is the primary route for water-soluble drugs; forced alkaline diuresis enhances salicylate and barbiturate elimination.

Hypoalbuminemia increases free fraction of highly protein-bound drugs (phenobarbital, NSAIDs); reduce dose to avoid toxicity.

Chloramphenicol is a potent CYP450 inhibitor that dramatically prolongs phenobarbital half-life in dogs — a classic drug-drug interaction.

Last updated: July 2026

Pharmacokinetics (PK) describes what the body does to a drug — absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics (PD) describes what the drug does to the body. The VTNE tests both, but the ADME framework is the more frequently examined because species differences in metabolism explain why a drug safe in dogs is lethal in cats (acetaminophen) and why dose intervals differ across species.

Absorption

Absorption is the movement of drug from the site of administration into systemic circulation. Rate and extent (bioavailability) depend on route, drug formulation, and patient factors:

Intravenous (IV) — 100% bioavailability by definition (no absorption barrier); fastest onset; preferred for emergencies and precise titration (anesthesia induction, CRI analgesia).

Intramuscular (IM) — aqueous solutions absorbed within 10 to 30 minutes; oil-based depots (e.g., penicillin G benzathine) extend duration for days; dependent on muscle blood flow — shock and dehydration slow absorption.

Subcutaneous (SQ/SC) — slower than IM; useful for sustained absorption (insulin, fluids, vaccines); affected by peripheral perfusion.

Oral (PO) — most convenient and least reliable; subject to first-pass hepatic metabolism (a fraction of drug is metabolized in the liver before reaching systemic circulation); gastric pH, presence of food, vomiting, and GI transit time all alter bioavailability. Cats have higher gastric pH than dogs and may absorb acid-labile drugs differently.

Transdermal — fentanyl patches, selegiline, methimazole in cats; slow and variable onset; cats' thinner skin and grooming behavior complicate dosing.

Topical/local — otic, ophthalmic, dermal; minimal systemic absorption unless barrier compromised.

The pH-partition hypothesis predicts absorption: non-ionized (lipid-soluble) drug crosses membranes; ionized (water-soluble) drug stays in compartment. Weak acids (aspirin, penicillins, barbiturates) are non-ionized in acidic stomach and ionized in alkaline small intestine; weak bases (opioids, local anesthetics, antihistamines) are non-ionized in alkaline environments. Drug interactions that alter gastric pH (omeprazole, H2 blockers) can shift absorption of pH-dependent drugs.

Distribution

Once in plasma, drugs distribute based on:

Protein binding — acidic drugs bind albumin; basic drugs bind alpha-1-acid glycoprotein. Only free (unbound) drug is pharmacologically active and available for metabolism and excretion. Hypoalbuminemia (liver disease, nephrotic syndrome, malnutrition) increases free fraction of highly protein-bound drugs (phenobarbital, NSAIDs) — reduce dose.

Lipid solubility — highly lipophilic drugs (diazepam, barbiturates, anesthetics) cross the blood-brain barrier readily; this is why propofol produces rapid induction and redistribution.

Volume of distribution (Vd) — describes apparent volume a drug occupies; high Vd concentrates in tissues (digoxin); low Vd stays in plasma (gentamicin).

Special barriers — blood-brain barrier (excludes ionized, protein-bound, large molecules); placental barrier (most drugs cross — teratogenic risk); mammary gland (drug residues in milk — relevant for lactating animals and food-animal withdrawal times).

Species-specific distribution notes: cats have less body fat than dogs on average, so lipid-soluble drugs redistribute less; neonates have higher total body water and lower albumin (about 60 percent of adult levels in the first weeks), so loading doses of water-soluble drugs are higher per kg but free fractions of bound drugs are higher.

Metabolism

Metabolism (biotransformation) converts lipophilic drugs to more hydrophilic metabolites for excretion — usually inactivating the drug, but occasionally activating prodrugs (enrofloxacin to ciprofloxacin; prednisone to prednisolone in the liver). Two phases:

Phase I — oxidative, reductive, hydrolytic reactions (mostly cytochrome P450 family). Adds or unmasks a functional group. Cats have significantly lower hepatic glucuronidation (a Phase II pathway) than dogs — the feline UGT1A6 and UGT2B7 isoforms that conjugate phenolic drugs are minimally expressed. This single species difference explains why acetaminophen (paracetamol) is fatal to cats : acetaminophen is metabolized in Phase I to NAPQI (a reactive quinone imine); in dogs and humans, glutathione conjugates NAPQI via glucuronidation and sulfation and excretes it. In cats, depleted glutathione and weak glucuronidation allow NAPQI to accumulate, causing methemoglobinemia, Heinz body anemia, and hepatic necrosis. Even one 325-mg tablet is lethal to an average cat. N-acetylcysteine (NAC) is the antidote — it replenishes glutathione and directly conjugates NAPQI.

Phase II — conjugation (glucuronidation, sulfation, acetylation, glutathione). Cats favor sulfation over glucuronidation; dogs have both pathways; pigs lack sulfate conjugation for some substrates. This is why carprofen is well-tolerated in dogs (mostly biliary excretion, minimal Phase II) but is used cautiously in cats (only the injectable form is approved in cats in the U.S., with strict dosing intervals).

Cytochrome P450 inducers (phenobarbital, rifampin, glucocorticoids) speed metabolism of co-administered drugs, reducing their effect; inhibitors (chloramphenicol, cimetidine, fluoxetine, ketoconazole, itraconazole) slow metabolism, increasing effect or toxicity. Chloramphenicol inhibits P450 and dramatically prolongs phenobarbital half-life in dogs — a classic VTNE drug-drug interaction.

Excretion

Excretion removes drug or metabolite from the body. The kidney is the primary route for water-soluble drugs and metabolites:

Glomerular filtration — passive; only free (unbound) drug filtered; protein-bound drug retained in plasma.

Tubular secretion — active transport (OAT for acids, OCT for bases); competition causes interactions (probenecid blocks penicillin secretion, prolonging its half-life — useful therapeutically).

Tubular reabsorption — passive, pH-dependent; acidic urine (carnivores) reabsorbs weak acids (extends half-life of aspirin, barbiturates); alkaline urine (herbivores, post-IV bicarbonate) reabsorbs weak bases. Forced alkaline diuresis with sodium bicarbonate enhances salicylate (aspirin) and barbiturate excretion in toxicosis.

Biliary excretion: some drugs (erythromycin, ampicillin, some NSAIDs) are excreted in bile; enterohepatic recirculation prolongs half-life when intestinal bacteria deconjugate the metabolite and it is reabsorbed — this is why repeated activated charcoal every 4 to 8 hours enhances elimination of drugs that undergo enterohepatic recirculation (tricyclic antidepressants, phenobarbital, theobromine).

Renal disease reduces clearance of renally excreted drugs (aminoglycosides, penicillins, furosemide, gabapentin, digoxin) — adjust dose or interval. Hepatic disease reduces clearance of hepatically cleared drugs (diazepam, phenobarbital, NSAIDs, lidocaine); cats with hepatic lipidosis have prolonged recovery from benzodiazepines. Always consider the interaction between organ function and clearance route before administering drugs to a patient with compromised liver or kidney function.